Schacker T, Collier AC, Hughes J, Shea T, Corey L: Clinical and epidemiologic features of primary HIV infection. Ann Intern Med. 1996, 125 (4): 257-264.
Article
CAS
PubMed
Google Scholar
Chiodi F, Sonnerborg A, Albert J, Gaines H, Norkrans G, Hagberg L, Asjo B, Strannegard O, Fenyo EM: Human immunodeficiency virus infection of the brain. I. Virus isolation and detection of HIV specific antibodies in the cerebrospinal fluid of patients with varying clinical conditions. J Neurol Sci. 1988, 85 (3): 245-257. 10.1016/0022-510X(88)90184-0.
Article
CAS
PubMed
Google Scholar
Budka H: Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1991, 1 (3): 163-175.
Article
CAS
PubMed
Google Scholar
Navia BA, Cho ES, Petito CK, Price RW: The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986, 19 (6): 525-535. 10.1002/ana.410190603.
Article
CAS
PubMed
Google Scholar
Wiley CA, Soontornniyomkij V, Radhakrishnan L, Masliah E, Mellors J, Hermann SA, Dailey P, Achim CL: Distribution of brain HIV load in AIDS. Brain Pathol. 1998, 8 (2): 277-284.
Article
CAS
PubMed
Google Scholar
An SF, Groves M, Giometto B, Beckett AA, Scaravilli F: Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neuropathol (Berl). 1999, 98 (5): 481-487. 10.1007/s004010051113.
Article
CAS
Google Scholar
Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD: Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol. 1996, 39 (6): 705-711. 10.1002/ana.410390606.
Article
CAS
PubMed
Google Scholar
Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB: Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A. 1986, 83 (18): 7089-7093. 10.1073/pnas.83.18.7089.
Article
CAS
PubMed
PubMed Central
Google Scholar
Andersson L, Blennow K, Fuchs D, Svennerholm B, Gisslen M: Increased cerebrospinal fluid protein tau concentration in neuro-AIDS. J Neurol Sci. 1999, 171 (2): 92-96. 10.1016/S0022-510X(99)00253-1.
Article
CAS
PubMed
Google Scholar
Brew BJ, Dunbar N, Pemberton L, Kaldor J: Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. J Infect Dis. 1996, 174 (2): 294-298.
Article
CAS
PubMed
Google Scholar
Hagberg L, Fuchs D, Rosengren L, Gisslen M: Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients. J Neuroimmunol. 2000, 102 (1): 51-55. 10.1016/S0165-5728(99)00150-2.
Article
CAS
PubMed
Google Scholar
Fuchs D, Chiodi F, Albert J, Asjo B, Hagberg L, Hausen A, Norkrans G, Reibnegger G, Werner ER, Wachter H: Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. Aids. 1989, 3 (5): 285-288.
Article
CAS
PubMed
Google Scholar
Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D: Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis. 1993, 168 (5): 1285-1288.
Article
CAS
PubMed
Google Scholar
Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelso C: Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem. 1996, 67 (5): 2013-2018.
Article
CAS
PubMed
Google Scholar
Norgren N, Rosengren L, Stigbrand T: Elevated neurofilament levels in neurological diseases. Brain Res. 2003, 987 (1): 25-31. 10.1016/S0006-8993(03)03219-0.
Article
CAS
PubMed
Google Scholar
Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E: Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol Chem Neuropathol. 1995, 26 (3): 231-245.
Article
CAS
PubMed
Google Scholar
Rosengren LE, Wikkelso C, Hagberg L: A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neurosci Methods. 1994, 51 (2): 197-204. 10.1016/0165-0270(94)90011-6.
Article
CAS
PubMed
Google Scholar
Andersson LM, Fredman P, Lekman A, Rosengren L, Gisslen M: Increased cerebrospinal fluid ganglioside GD3 concentrations as a marker of microglial activation in HIV type 1 infection. AIDS Res Hum Retroviruses. 1998, 14 (12): 1065-1069.
Article
CAS
PubMed
Google Scholar
Studahl M, Rosengren L, Gunther G, Hagberg L: Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J Neurol. 2000, 247 (8): 636-642. 10.1007/s004150070134.
Article
CAS
PubMed
Google Scholar
Marshall DW, Brey RL, Butzin CA, Lucey DR, Abbadessa SM, Boswell RN: CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel. J Acquir Immune Defic Syndr. 1991, 4 (8): 777-781.
CAS
PubMed
Google Scholar
Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Boswell RN: Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol. 1988, 45 (9): 954-958.
Article
CAS
PubMed
Google Scholar
McArthur JC, Nance-Sproson TE, Griffin DE, Hoover D, Selnes OA, Miller EN, Margolick JB, Cohen BA, Farzadegan H, Saah A: The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study. Neurology. 1992, 42 (9): 1707-1712.
Article
CAS
PubMed
Google Scholar
Petito CK, Cash KS: Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol. 1992, 32 (5): 658-666. 10.1002/ana.410320509.
Article
CAS
PubMed
Google Scholar
Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL: Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol. 1999, 155 (6): 1915-1927.
Article
CAS
PubMed
PubMed Central
Google Scholar
Elovaara I, Seppala I, Poutiainen E, Suni J, Valle SL: Intrathecal humoral immunologic response in neurologically symptomatic and asymptomatic patients with human immunodeficiency virus infection. Neurology. 1988, 38 (9): 1451-1456.
Article
CAS
PubMed
Google Scholar
Brew BJ, Pemberton L, Cunningham P, Law MG: Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis. 1997, 175 (4): 963-966.
Article
CAS
PubMed
Google Scholar
Cinque P, Vago L, Ceresa D, Mainini F, Terreni MR, Vagani A, Torri W, Bossolasco S, Lazzarin A: Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. Aids. 1998, 12 (4): 389-394.
Article
CAS
PubMed
Google Scholar
Di Stefano M, Monno L, Fiore JR, Buccoliero G, Appice A, Perulli LM, Pastore G, Angarano G: Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype. Aids. 1998, 12 (7): 737-743. 10.1097/00002030-199807000-00010.
Article
CAS
PubMed
Google Scholar
Robertson K, Fiscus S, Kapoor C, Robertson W, Schneider G, Shepard R, Howe L, Silva S, Hall C: CSF, plasma viral load and HIV associated dementia. J Neurovirol. 1998, 4 (1): 90-94.
Article
CAS
PubMed
Google Scholar
Dore GJ, Li Y, McDonald A, Ree H, Kaldor JM: Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr. 2002, 29 (4): 388-395.
Article
PubMed
Google Scholar
Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L: HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002, 8 (2): 136-142.
Article
PubMed
Google Scholar
Marra CM, Lockhart D, Zunt JR, Perrin M, Coombs RW, Collier AC: Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology. 2003, 60 (8): 1388-1390.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dougherty RH, Skolasky RLJ, McArthur JC: Progression of HIV-associated dementia treated with HAART. AIDS Read. 2002, 12 (2): 69-74.
PubMed
Google Scholar
Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, Hall CD: Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr. 2004, 36 (1): 562-566.
Article
PubMed
Google Scholar
Price RW, Brew BJ: The AIDS dementia complex. J Infect Dis. 1988, 158 (5): 1079-1083.
Article
CAS
PubMed
Google Scholar
Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991, 41 (6): 778-785.
Abdulle S, Hagberg L, Svennerholm B, Fuchs D, Gisslen M: Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection. Aids. 2002, 16 (16): 2145-2149. 10.1097/00002030-200211080-00006.
Article
CAS
PubMed
Google Scholar
Gisslen M, Rosengren L, Hagberg L, Deeks SG, Price RW: Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection. AIDS Res Ther. 2005, 2: 6-10.1186/1742-6405-2-6.
Article
PubMed
PubMed Central
Google Scholar
Malmestrom C, Haghighi S, Rosengren L, Andersen O, Lycke J: Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS. Neurology. 2003, 61 (12): 1720-1725.
Article
CAS
PubMed
Google Scholar
Abdulle S, Hagberg L, Gisslen M: Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients. HIV Med. 2005, 6 (3): 164-169. 10.1111/j.1468-1293.2005.00281.x.
Article
CAS
PubMed
Google Scholar
Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, Nance-Sproson TE, Royal W, Dal Pan GJ, McArthur JC: Variable progression of HIV-associated dementia. Neurology. 1998, 50 (6): 1814-1820.
Article
CAS
PubMed
Google Scholar